Webinar Hub

7,113 upcoming
MedicalZoom

Topics › Medical & Clinical

Theralase®: A Clinical Perspective of Light-Activated Ruvidar® and Its Potential Role in Bladder Cancer Care

When
Length
1 hr
Platform
Zoom
Topic
Medical & Clinical
Price
Free

About this webinar

To truly evaluate the commercial potential of a novel oncology treatment, investors must understand how it is viewed from the clinical frontlines. In this exclusive webinar, Theralase® Technologies Inc. (TSXV: TLT | OTCQB: TLTFF) will provide an in-depth clinical perspective on Ruvidar®, the company’s proprietary energy-activated cancer treatment system currently under clinical trials for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC).

Theralase® Chairman, President & CEO Roger DuMoulin-White and US Principal Investigator Dr. Neal Shore will join host Michael Lubinsky to talk about the safety and efficacy profile of Ruvidar® based on the treatment’s latest interim Study II clinical results. The discussion includes an independent analysis of what specific evidence physicians require to ensure this localized treatment translates into meaningful, safe, and durable benefits for patients.

The featured speakers will also outline the potential role of Ruvidar® in the future of bladder cancer care, as well as the real-world operational hurdles that must be addressed, such as physician training, insurance coverage, and clinic readiness.

Register now to learn about the company’s roadmap of the regulatory and clinical milestones to watch over the next 12 to 18 months.

Learn more: https://theralase.com

More Medical webinars 661

All Medical →

All Medical (661)